These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2769476)

  • 1. [Clinical evaluation of immunosuppressive factors (IAP-immunosuppressive acidic protein, IS-immunosuppressive substance) in head and neck cancer].
    Saito T; Dake Y; Kakiuti H; Kato Y; Kuki K; Hayashi Y; Yokota M; Kinoshita K; Kuki S; Kimura T
    Nihon Jibiinkoka Gakkai Kaiho; 1989 Apr; 92(4):588-96. PubMed ID: 2769476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive substance in the sera of head and neck cancer patients.
    Yamanaka N; Harabuchi Y; Himi T; Kataura A
    Cancer; 1988 Oct; 62(7):1293-8. PubMed ID: 3416271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey of immunosuppressive acidic protein and other immunological parameters in head and neck cancer patients.
    Nakashima T; Tanaka M; Okamura S
    J Laryngol Otol; 1991 Nov; 105(11):939-45. PubMed ID: 1761949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of serum immunosuppressive acidic protein (IAP) and acid soluble glycoproteins (ASP) in patients with malignant tumors].
    Shibasaki K; Soga K; Toshima M; Aikawa K; Tsuruya T; Itoh T; Takahashi Y; Tsuchimochi M; Mataga I; Tsuchikawa K
    Shigaku; 1989 Aug; 77(2):701-11. PubMed ID: 2489324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum immunosuppressive acidic protein (IAP) in patients with malignant head and neck tumors.
    Yokode Y; Furusaka T; Kida A; Tomita H
    Auris Nasus Larynx; 1985; 12 Suppl 2():S221-5. PubMed ID: 3879742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of the serum level of immunosuppressive acidic protein (IAP) and immunosuppressive substance (IS) in gastric cancer patients].
    Sakita M; Yamane T; Kasuga M; Torii T; Imai H; Kageyama N; Fujita Y; Majima S
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1755-64. PubMed ID: 7184372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum immunosuppressive acidic protein reflects systemic deterioration of colorectal cancer patient condition.
    Toiyama Y; Miki C; Inoue Y; Okugawa Y; Koike Y; Watanabe H; Yokoe T; Hiro J; Ojima E; Tanaka K; Kusunoki M
    J Surg Oncol; 2008 Apr; 97(5):404-8. PubMed ID: 18181167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum immunosuppressive acidic protein levels in patients with severe acute pancreatitis.
    Shinzeki M; Ueda T; Takeyama Y; Yasuda T; Sawa H; Nakajima T; Matsumoto I; Fujita T; Ajiki T; Fujino Y; Kuroda Y
    Pancreas; 2007 Nov; 35(4):327-33. PubMed ID: 18090238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum immunosuppressive acidic protein as an interleukin-6 related index of deteriorating condition in gastric cancer patients.
    Ikuta S; Miki C; Tanaka K; Konishi N; Mohri Y; Tonouchi H; Kusunoki M
    Dig Surg; 2003; 20(6):532-8. PubMed ID: 14534376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunosuppressive acidic protein (IAP) and immunosuppressive substance (ISS) in patients with renal cell carcinoma].
    Yamazaki K; Kumamoto Y; Tsukamoto T; Ohmura K; Miyao N; Yoshioka M; Iwasawa A
    Hinyokika Kiyo; 1991 May; 37(5):467-74. PubMed ID: 1858580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical investigation of serum immunosuppressive acidic protein (IAP) in patients with gastric cancer].
    Kageyama T; Oyabu H; Ohshiba S
    Gan No Rinsho; 1986 Sep; 32(11):1416-20. PubMed ID: 3773269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive acidic protein in patients with gynecologic cancer.
    Sawada M; Okudaira Y; Matsui Y; Shimizu Y
    Cancer; 1984 Aug; 54(4):652-6. PubMed ID: 6744202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic value of serum immunosuppressive acidic protein in renal cell carcinoma].
    Matsumoto K; Iwamura M; Muramoto M; Suyama K; Tabata K; Minei S; Hirai S; Baba S
    Nihon Hinyokika Gakkai Zasshi; 2002 May; 93(4):548-54. PubMed ID: 12056039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunosuppressive acidic protein (IAP) in gynecologic malignant tumors and its relationship with other immunosuppressive substances and cell-mediated immunity].
    Takada M
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):237-44. PubMed ID: 6881975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunosuppressive acidic glycoprotein (IAP) and immunosuppressive substance].
    Ogoshi K; Kondoh Y; Nakasaki H; Tajima T; Mitomi T
    Gan No Rinsho; 1983 Aug; 29(9):987-90. PubMed ID: 6688640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of immunosuppressive acid protein (IAP) in patients with rheumatoid arthritis].
    Ueyoshi A; Ota K
    Ryumachi; 1992 Apr; 32(2):131-4. PubMed ID: 1595004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum immunosuppressive acidic protein as a tumor marker for renal cell carcinoma.
    Igarashi T; Murakami S; Isaka S; Okano T; Shimazaki J; Matsuzaki O
    Eur Urol; 1991; 19(4):332-5. PubMed ID: 1915542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum levels of immunosuppressive acidic protein (IAP) in various disease states and their clinical significance].
    Kikuchi S
    Nihon Geka Gakkai Zasshi; 1984 Apr; 85(4):283-99. PubMed ID: 6749105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum immunosuppressive acidic protein levels in blackfoot disease patients and cancer patients.
    Lu FJ; Chang KJ; Chen BH; Liaw FR; Liau SR; Chen HY
    J Formos Med Assoc; 1990 Apr; 89(4):255-8. PubMed ID: 1976740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive acidic protein serum levels in breast cancer patients in a reference to CA 15-3 levels.
    Cohen AD; Shoenfeld Y; Gopas J; Cohen Y
    Breast Cancer Res Treat; 1994; 30(2):197-200. PubMed ID: 7949217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.